Valuation Update With 7 Day Price Move • May 07
Investor sentiment deteriorates as stock falls 35% After last week's 35% share price decline to US$1.83, the stock trades at a trailing P/E ratio of 3.8x. Average trailing P/E is 18x in the Consumer Retailing industry in the US. Total loss to shareholders of 100% over the past three years. Buy Or Sell Opportunity • Apr 24
Now 33% undervalued after recent price drop Over the last 90 days, the stock has fallen 91% to US$0.18. The fair value is estimated to be US$0.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Apr 21
Full year 2025 earnings released: EPS: US$0.035 (vs US$3.68 in FY 2024) Full year 2025 results: EPS: US$0.035 (down from US$3.68 in FY 2024). Revenue: US$18.3m (flat on FY 2024). Net income: US$187.5k (down 75% from FY 2024). Profit margin: 1.0% (down from 4.1% in FY 2024). New Risk • Mar 24
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 13% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 113x increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Annonce • Jan 07
Chanson International Holding has filed a Follow-on Equity Offering in the amount of $219.375 million. Chanson International Holding has filed a Follow-on Equity Offering in the amount of $219.375 million.
Security Name: Class A Ordinary Shares
Security Type: Common Stock
Transaction Features: At the Market Offering Reported Earnings • Sep 08
First half 2025 earnings released: US$2.87 loss per share (vs US$0.15 profit in 1H 2024) First half 2025 results: US$2.87 loss per share (down from US$0.15 profit in 1H 2024). Revenue: US$8.69m (up 15% from 1H 2024). Net loss: US$1.05m (down US$1.07m from profit in 1H 2024). New Risk • Aug 18
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 248% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). Earnings have declined by 30% per year over the past 5 years. Shareholders have been substantially diluted in the past year (248% increase in shares outstanding). Market cap is less than US$10m (US$1.71m market cap). Annonce • Jun 17
Chanson International Holding has completed a Composite Units Offering in the amount of $8 million. Chanson International Holding has completed a Composite Units Offering in the amount of $8 million.
Security Name: Units
Security Type: Equity/Derivative Unit
Securities Offered: 16,000,000
Price\Range: $0.5
Discount Per Security: $0.0375 New Risk • Jun 15
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$6.14m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (35% average weekly change). Earnings have declined by 30% per year over the past 5 years. Shareholders have been substantially diluted in the past year (120% increase in shares outstanding). Market cap is less than US$10m (US$6.14m market cap). Annonce • May 08
Chanson International Holding Refines Natural Sweetener Blend for Healthier Beverages and Baked Goods Chanson International Holding announced an innovation in sugar reduction: an optimized blend of natural sweeteners that enhances both flavor and functionality in beverages and baked goods. This reformulation marks a key step forward in the Chanson's health-focused product strategy, aligning with growing global demand for lower-sugar, clean-label foods without compromising taste or texture. Instead of introducing a new compound, Chanson's research and development team focused on optimizing the ratio of existing natural sweeteners--s specially combining Brazzein, a sweet-tasting protein, with Mogroside V from monk fruit. The new formulation delivers a more harmonious sweetness profile with improved aftertaste control and better heat stability--effectively addressing the common limitations of sugar substitutes in baking and hot beverages-- while containing zero calories. This improved formula has already been applied to Chanson's beverage and bakery products under its coffee brand, Soul Song. Since the low-sugar product series debut in July 2024, it has gained initial positive consumer reception. The early result reflects strong consumer interest in the new sweetener blend. Building on this, Chanson plans to introduce the reformulated products across three stores in New York and over 50 stores in Xinjiang by late 2025. Reported Earnings • Apr 06
Full year 2024 earnings released: EPS: US$0.046 (vs US$0.003 in FY 2023) Full year 2024 results: EPS: US$0.046 (up from US$0.003 in FY 2023). Revenue: US$18.2m (up 5.7% from FY 2023). Net income: US$756.3k (up US$722.7k from FY 2023). Profit margin: 4.1% (up from 0.2% in FY 2023). The increase in margin was driven by higher revenue. Annonce • Mar 14
Chanson International Holding Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency Chanson International Holding announced that on March 10, 2025, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the closing bid price of its Class A ordinary shares over the past 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2) to maintain a minimum bid price of $1 per share. The notification has no immediate effect on the listing or trading of the Company’s Class A ordinary shares on Nasdaq. Nasdaq has provided the Company with a 180 calendar days compliance period, or until September 8, 2025, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting. The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement. New Risk • Jan 24
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$17.6m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (33% average weekly change). Earnings have declined by 57% per year over the past 5 years. Shareholders have been substantially diluted in the past year (73% increase in shares outstanding). Minor Risk Market cap is less than US$100m (US$17.6m market cap). Reported Earnings • Sep 30
First half 2024 earnings released: EPS: US$0.002 (vs US$0.027 in 1H 2023) First half 2024 results: EPS: US$0.002 (down from US$0.027 in 1H 2023). Revenue: US$7.54m (down 14% from 1H 2023). Net income: US$23.4k (down 92% from 1H 2023). Profit margin: 0.3% (down from 3.2% in 1H 2023). New Risk • Sep 29
New major risk - Revenue and earnings growth Earnings have declined by 57% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 57% per year over the past 5 years. Shareholders have been substantially diluted in the past year (138% increase in shares outstanding). Minor Risk Market cap is less than US$100m (US$61.0m market cap). New Risk • Sep 19
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 138% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Shareholders have been substantially diluted in the past year (138% increase in shares outstanding). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (US$55.7m market cap). New Risk • Sep 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (38% increase in shares outstanding). Market cap is less than US$100m (US$24.2m market cap). Board Change • Sep 01
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairman of the Board & CEO Gang Li is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Annonce • Aug 23
Chanson International Holding has filed a Follow-on Equity Offering in the amount of $37.18 million. Chanson International Holding has filed a Follow-on Equity Offering in the amount of $37.18 million.
Security Name: Class A Ordinary Shares
Security Type: Common Stock
Securities Offered: 10,000,000
Security Name: Pre-Funded Warrants
Security Type: Equity Warrant
Securities Offered: 10,000,000
Security Name: Common Warrants
Security Type: Equity Warrant
Securities Offered: 10,000,000 Annonce • Aug 22
Chanson International Holding Announces Board Changes Chanson International Holding on August 12, 2024 announced that Mr. Shouhua Nie notified the Company of his resignation as a Director, effective August 12, 2024. Mr. Nie has advised that his resignation was due to personal reasons. to Fill in the Vacancy Created by the Resignation of Mr. Nie, on August 12, 2024, the Nominating and Corporate Governance Committee (The “Nominating Committee”) of the Board of Directors (The “Board”) of the Company Recommended, and the Board Appointed, Mr. Jie Li (“Mr. Li”) to Serve as A Director of the Company, A Member of the Audit Committee of the Board, the Chairperson of the Compensation Committee of the Board, and A Member of the Nominating Committee, Effective August 12, 2024. Mr. Li, Age 36, Has Worked as A Lawyer At Beijing Deheng Law Offices (Urumqi) Since April 2016. He Received His Bachelor of Laws Degree from Shandong University of Finance and Economics in 2008. Reported Earnings • May 01
Full year 2023 earnings released: EPS: US$0.003 (vs US$0.14 loss in FY 2022) Full year 2023 results: EPS: US$0.003 (up from US$0.14 loss in FY 2022). Revenue: US$17.3m (up 30% from FY 2022). Net income: US$33.6k (up US$1.32m from FY 2022). Profit margin: 0.2% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. New Risk • Apr 23
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 76% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (US$22.2m market cap). Annonce • Dec 15
Chanson International Holding Announces the Plan to Grow Its New Coffee Brand in China Chanson International Holding announced that the Company had reached a significant milestone in the Chinese market by having operated seven new cafes under the Company's new coffee brand, Soul Song, in China. Soul Song adopts the "blend bean concept," which emphasizes not only the selection of high-quality coffee beans but also the art of blending different coffee beans. This method allows for the fusion of multiple flavors, the creation of varied and complex flavors, and the provision of a wider range of choices to the customers. Board Change • Dec 13
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (3 non-independent directors). Chairman of the Board & CEO Gang Li is the most experienced director on the board, commencing their role in 2019. Independent Director Yong Du was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Annonce • Dec 02
Chanson International Holding Announces Director Changes On November 27, 2023, Mr. Yuchen Liu notified Chanson International Holding (the “Company”) of his resignation as a director of the Company, effective November 27, 2023. Mr. Liu has advised that his resignation was due to personal reasons and not as a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. To fill in the vacancy created by the resignation of Mr. Liu, on November 27, 2023, the Nominating and Corporate Governance Committee (the “Nominating Committee”) of the board of directors (the “Board”) of the Company recommended, and the Board appointed, Mr. Jin Wang (“Mr. Wang”) to serve as a director of the Company, effective November 27, 2023. Mr. Wang, age 43, served as the Financial Manager at JunYe Investment Company from January 2019 to December 2022 and his major responsibilities included financial policy making and human resources management. Mr. Wang served as the Compliance Manager at Xiangcai Securities Co. Ltd. from January 2015 to December 2018, where he supervised industry compliance matters. He received his Bachelor of Arts degree in Literature from Xiangtan University in 2002. Reported Earnings • Oct 08
First half 2023 earnings released: EPS: US$0.027 (vs US$0.025 in 1H 2022) First half 2023 results: EPS: US$0.027 (up from US$0.025 in 1H 2022). Revenue: US$8.81m (up 3.1% from 1H 2022). Net income: US$284.8k (up 29% from 1H 2022). Profit margin: 3.2% (up from 2.6% in 1H 2022). Board Change • Sep 01
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairman of the Board & CEO Gang Li is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • May 05
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to US$1.91, the stock trades at a trailing P/E ratio of 79.9x. Average trailing P/E is 21x in the Consumer Retailing industry in the US. Valuation Update With 7 Day Price Move • Apr 21
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to US$1.48, the stock trades at a trailing P/E ratio of 61.9x. Average trailing P/E is 20x in the Consumer Retailing industry in the US.